Loading patent…
AssigneeAlphyn Biologics, Inc.
InventorsGary Michael PEKOE, Jazmyne Kristyne MINK, Steven Aaron PENTELNIK, Neal G. KOLLER
Estimating the term…
The present disclosure provides for a method of treating a bacterial colonization or primary or secondary bacterial infection of an underlying skin disorder in a subject via the topical administration of a pharmaceutical composition comprising a therapeutically effective amount of an extract of the Croton lechleri tree. Additionally the present disclosure provides for a method of treating a bacterial colonization or primary or secondary bacterial infection of the nasal mucosa in a subject via the nasal administration of a pharmaceutical composition comprising a therapeutically effective amount of an extract of the Croton lechleri tree. Also provided are details of studies on the effectiveness of an extract of the Croton lechleri tree on bacterial pathogens.
A method of treating atopic dermatitis in a subject in need thereof comprising topically administering to affected areas of the subject a pharmaceutical composition containing a therapeutically effective amount of filtered latex of Croton lechleri, wherein the therapeutically effective amount of filtered latex of Croton lechleri is about 10 wt % to about 60 wt %, and wherein the atopic dermatitis is treated.
A method of treating atopic dermatitis accompanied by bacterial colonization or primary or secondary bacterial infection in a subject in need thereof comprising topically administering to affected areas of the subject a pharmaceutical composition containing a therapeutically effective amount of filtered latex of Croton lechleri, wherein the therapeutically effective amount of filtered latex of Croton lechleri is about 10 wt % to about 60 wt %, and wherein the atopic dermatitis is treated.
Dependencies are inferred from the claim text.